share_log

Oppenheimer Upgrades AtriCure to Outperform, Announces $32 Price Target

Moomoo 24/7 ·  Apr 23 07:40

Oppenheimer analyst Suraj Kalia upgrades AtriCure (NASDAQ:ATRC) from Perform to Outperform and announces $32 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment